N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-(2-(1H-1,2,3-TRIAZOL-1-YL)ETHOXY)-4-QUINAZOLINAMINE
UNII D8NQ3REV56
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(2-(1h-1,2,3-triazol-1-yl)ethoxy)-4-quinazolinamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D8NQ3REV56.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 413599-62-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H16BrFN6O2 YBTGTVGEKMZEQX-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(2-(1h-1,2,3-triazol-1-yl)ethoxy)-4-quinazolinamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.